Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
Clinical trial NCT02129751 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT02129751
- Sponsor
- Bausch Health Americas, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-07-01
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.